关键信息
-
基因名
FKHL18
- 应用
-
别名
FOXS1; FKHL18; FREAC10Forkhead box protein S1; Forkhead-like 18 protein; Forkhead-related transcription factor 10; FREAC-10
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O43638
-
表达区间
1-330aa
-
氨基酸序列
MQQQPLPGPGAPTTEPTKPPYSYIALIAMAIQSSPGQRATLSGIYRYIMGRFAFYRHNRPGWQNSIRHNLSLNECFVKVPRDDRKPGKGSYWTLDPDCHDMFEHGSFLRRRRRFTRQTGAEGTRGPAKARRGPLRATSQDPGVPNATTGRQCSFPPELPDPKGLSFGGLVGAMPASMCPATTDGRPRPPMEPKEISTPKPACPGELPVATSSSSCPAFGFPAGFSEAESFNKAPTPVLSPESGIGSSYQCRLQALNFCMGADPGLEHLLASAAPSPAPPTPPGSLRAPLPLPTDHKEPWVAGGFPVQGGSGYPLGLTPCLYRTPGMFFFE
-
分子量
61.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
FKHL18 is a member of the forkhead box (FOX) family of transcription factors, which play crucial roles in various biological processes, including development, cell proliferation, and differentiation. The study of FKHL18 is particularly significant due to its involvement in regulating gene expression in response to different physiological and pathological conditions. Recent research has highlighted the potential impact of FKHL18 on cellular processes related to cancer progression and metabolic disorders. Understanding the structure and function of FKHL18 through recombinant protein studies can provide valuable insights into its mechanisms of action and interaction with other cellular components. Moreover, the generation of FKHL18 recombinant proteins enables investigators to assess its functional properties in vitro and in vivo, paving the way for therapeutic applications targeting FKHL18-related pathways. By exploring the biochemical and biophysical characteristics of FKHL18, researchers can elucidate its role in transcriptional regulation and its potential as a biomarker or therapeutic target in disease contexts. Overall, FKHL18 research is poised to contribute to a deeper understanding of the FOX family transcription factors and their relevance in health and disease.
